Development of Focal Nodular Hyperplasia Post Dual Anti-HER2 Blockade with Pertuzumab and Trastuzumab in a Patient with Breast Cancer: A Case Report and Literature Review

Targeted therapies like trastuzumab and pertuzumab have substantially improved outcomes in HER2-positive breast cancer with rare reports of significant adverse events. One such rarely reported adverse event is focal nodular hyperplasia (FNH), an uncommon hepatic condition, typically benign and asymp...

Full description

Saved in:
Bibliographic Details
Main Authors: Udip Maheshwari, Disha Morzaria, Vashishth Maniar, Ritu Dave, Nikhat Shaikh, Bhavin Jankharia, Karthik Ganesan
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd.
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1802637
Tags: Add Tag
No Tags, Be the first to tag this record!